Overview
StressMarq Biosciences Inc., founded in 2007, is a biotechnology company focused on developing and commercializing high-quality bioreagents for life science research, drug discovery, and preclinical studies. The company is internationally recognized for its expertise in neurodegenerative disease research tools, particularly protein aggregates such as alpha-synuclein, tau, amyloid beta, TDP-43, and SOD1 used in disease modeling for Alzheimer’s, Parkinson’s, ALS, and related disorders. In addition to its specialized neuroscience portfolio, StressMarq offers a broad range of antibodies, assay kits, recombinant proteins, and small molecules that support research in cancer biology, cellular stress, and signal transduction. The company distributes its products globally through a network of partners in over 45 countries and serves academic institutions, biotech companies, and pharmaceutical research organizations.
Key techniques
StressMarq reagents support specialized workflows in neuroscience, protein aggregation, and molecular biology research.
Product lines
StressMarq offers a diverse portfolio of life science reagents with a strong focus on neuroscience and protein aggregation research.
Antibodies ›
Biochemicals ›
Capabilities
StressMarq integrates advanced protein chemistry and molecular biology technologies to develop highly specialized research reagents.
QC & documentation
StressMarq provides detailed validation data and technical documentation to support reproducible experimental workflows.
Lead time & shipping
Shipping timelines depend on product availability and destination.